Section search
Enter a keyword or phrase to search all pages in this section:
Advanced searchArchive:
Looking for a previously published document in this section?
Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
Following our assessment of the latest safety evidence of venlafaxine, in particular relating to toxicity in overdose, we have updated prescribing advice.
Head office: 151 Buckingham Palace Road, Victoria, London, SW1W 9SZ
General enquiries: info@mhra.gsi.gov.uk
To contact us about this website, use our feedback form
Venlafaxine (Efexor) - summary of basis for regulatory position